Unicredit (UIH824) Cotización

Yea, ok. Sure you did. Nothing you say is true so take your BS elsewhere clown.

Trump Victory Certified, Democrats Cling to January 6 Dramatics

Conveniently forgetting their own election denial, Trump’s foes forge a narrative.

by Graham J Noble | Jan 7, 2025


The election deniers from 2016 became the fierce defenders of elect

Nice...🥳...I am holding 1/2 for now...

Institutional ownership had been 122.45% but jumped yesterday to:
Institutional Shares (Long) 79,498,386 - 124.29% (ex 13D/G)
Even more shorting?

Good morning scammybear

TNXP has Good News today --- see the link below!

https://finance.yahoo.com/news/tonix-pharmaceuticals-present-two-upcoming-120000518.html

He is a wolf in disguise.

Nice to log on and see this move...🥳

Could you give us a hint?

SVMH company announcement on 15th CEO worked at Tesla and has lower float than X***

Rest out $4s hit 4.12 

Many uses for EOP, including quantum computing. Seemingly everyone needs increased speed and bandwidth at remarkably lower power consumption and a small footprint: Can someone say, "right place, right time!"

https://www.laserfocusworld.com/optics/article/55140912/electro-optic-polymer

were you watching the same keynote as me?
I heard lots of timing relavant to the consumer products (it is CS after all). He mentioned TAM for a number of the new markets they are entering, but that is just it these are new markets - who can put a TAM on them when the capability to address th

Wolf-man jack more great news for CBD.

https://www.sciencedirect.com/science/article/abs/pii/S0166432824005643

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0310777

Legacies and Liabilities – Biden’s Parting Gifts

The waning days of President Biden could have long-ranging implications.

by Mark Angelides | Jan 7, 2025


Imagine for a moment the CEO of a Fortune 500 company who makes a series of decisions so dama

.20 + 120% XTIA .. Nice one you, Final and Trend cashed in here. Seeing this will watch HOVR $1.13 for another round in future 

Crossroads Capital: Research Report

Conclusion

Nebius represents a compelling investment opportunity at a critical juncture in the AI infrastructure market, with multiple call options on what could be a leading full-stack AI platform. Still seen as a newcomer, the comp

IMRX...$3.67...🥳...Taking 1/2 off the table here from my $1.52 Alert...

georgie18

Member Level
Re: georgie18 post# 387979

Monday, January 06, 2025 1:24:01 PM

Post#
388095
of 388148
IMRX...$2.52...Off t

https://ir.unicycive.com/news/detail/92/unicycive-therapeutics-announces-publication-of-positive

https://ascpt.onlinelibrary.wiley.com/doi/10.1111/cts.70116

IMRX...$3.67...🥳...Taking 1/2 off the table here from my $1.52 Alert...

georgie18

Member Level
Re: georgie18 post# 387979

Monday, January 06, 2025 1:24:01 PM

Post#
388095
of 388148
IMRX...$2.52...Off t

IMRX...$3.67...🥳...Taking 1/2 off the table here from my $1.52 Alert...

georgie18

Member Level
Re: georgie18 post# 387979

Monday, January 06, 2025 1:24:01 PM

Post#
388095
of 388148
IMRX...$2.52...Off t

ALL OUT

so nice since fake news mod disappeared

SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results
TEL AVIV, Israel, Jan. 07, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development o